Inolife Technologies, Inc. (OTCPK:INOL) received $0.05 million in funding. Inolife Technologies will be using the proceeds from the sale of the note to spin off its existing service-based healthcare product marketing business, bring in new management and acquire a biopharma-based operating business with growth potential.